Key Clinical Features: This is an easy-to-transport mobile device
- Comprehensive Autonomic Nervous System (ANS) Assessment Evaluates the balance between the Sympathetic ("Fight or Flight") and Parasympathetic ("Rest and Digest") branches of the involuntary nervous system to identify physiological imbalances.
- Early Detection of Cardiac Autonomic Neuropathy (CAN) uses high-fidelity Heart Rate Variability (HRV) to detect early-stage nerve damage to the heart—a critical risk factor for silent heart attacks that are often missed by standard EKGs.
- Quantitative Sudomotor Function Testing measures the health of Small Fiber Nerves by evaluating sweat gland response. This is a primary diagnostic tool for identifying peripheral neuropathy in diabetic and hypertensive patients years before physical symptoms appear.
- Longitudinal "Homeostasis" Tracking Features a specialized Quarterly Monitoring Model to objectively track a patient’s progress. This allows for data-driven validation of how medications, diet, and lifestyle changes are physically improving the body’s stress resilience.
- Non-Invasive "Quick-Scan" Technology: A fully non-invasive, needle-free procedure that takes only 10–15 minutes. It utilizes comfortable finger and toe sensors to provide lab-grade diagnostic data without the need for stressful treadmill tests.
- Objective Stress & Fatigue Quantification provides a biological marker for the physical toll of chronic stress and fatigue, offering clinicians a clear "Homeostasis Score" to guide mental and physical wellness plans.
- Treatment Optimization & Titration Assists physicians in fine-tuning treatments (such as Beta-Blockers or Neuropathy medications) by showing the real-time physiological impact of the therapy on the patient's nervous system.
- Advanced Hemodynamic Regulation Monitoring evaluates how the body regulates blood pressure and heart rate during postural changes, providing vital insights for patients suffering from unexplained dizziness, fainting, or POTS.